BPC-157 10/TB-500 10 10vials

230.00

This blend combines BPC-157, a stable 15-amino-acid gastric peptide, with TB-500, the synthetic 7-amino-acid fragment (Ac-LKKTETQ-NH₂) of thymosin β4 that mediates actin-binding and cell-migration activity. In preclinical models, each peptide is studied for angiogenesis, cytoprotection, and tissue repair. When used together, the blend is investigated for its potential complementary effects, with BPC-157 supporting vascular integrity and nitric-oxide signaling while TB-500 enhances cell motility and actin dynamics.

        SPECIAL OFFER

          Please select all product options

          Product was out of stock

          share
          Description

          All products on this site are for research and development, laboratory, or analytical use only; they are not for human consumption, medical, diagnostic, cosmetic, veterinary, or any other non-research application. The statements and products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Honest Peptide is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under section 503B.

          Amino Acid Sequence

          BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

          TB-500: Ac-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ-NH₂)

          Molecular Formula

          BPC-157: C₃₈H₆₈N₁₀O₁₄ TB-500: C₃₈H₆₈N₁₀O₁₄

          Molecular Weight

          BPC-157: ~1,449.5 g/mol TB-500: ~802.9 g/mol

          PubChem CID

          BPC-157: 9947844 TB-500: 62707662

          CAS Number

          BPC-157: 137525-51-0 TB-500: 885340-08-9

          Vial Size

          3ml

          Contents

          Lyophilized powder, white/off-white color
           

          Mechanism of action

          Angiogenesis & Vascular Repair

          BPC-157 engages pro-angiogenic signaling (e.g., VEGF-linked pathways in injury models). The TB-500 fragment derives from Tβ4’s actin-binding region and is studied for endothelial/keratinocyte migration and microvascular remodeling.

          Cytoprotection & Anti-Inflammatory Effects

          BPC-157 modulates nitric-oxide–related cytoprotection in GI and soft-tissue models; TB-500 reports describe reduced inflammatory infiltration and supportive matrix effects in preclinical injury models.

          Anti-Inflammatory Cytokine Modulation

          Downregulates pro-inflammatory cytokines (e.g., TNF-α, IL-6) and upregulates anti-inflammatory mediators, creating a favorable environment for repair.

          Tissue Repair & Cell Migration

          BPC-157 enhances fibroblast activity and collagen deposition in wound/tendon models. TB-500’s LKKTETQ motif is associated with actin dynamics and cell migration in vitro and in vivo assay systems.
           

          Storage & handling

          Storage:

          Store the lyophilized vial in a cool, dry area protected from direct sunlight.